These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 21294722)
1. Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Lee YS; Amadi-Obi A; Yu CR; Egwuagu CE Immunology; 2011 Apr; 132(4):492-502. PubMed ID: 21294722 [TBL] [Abstract][Full Text] [Related]
2. Key role for IL-21 in experimental autoimmune uveitis. Wang L; Yu CR; Kim HP; Liao W; Telford WG; Egwuagu CE; Leonard WJ Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9542-7. PubMed ID: 21593413 [TBL] [Abstract][Full Text] [Related]
3. Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis. He C; Yu CR; Sun L; Mahdi RM; Larkin J; Egwuagu CE J Autoimmun; 2015 Aug; 62():31-8. PubMed ID: 26094775 [TBL] [Abstract][Full Text] [Related]
4. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements. Yu CR; Choi JK; Uche AN; Egwuagu CE J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603 [TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. Yu CR; Mahdi RR; Oh HM; Amadi-Obi A; Levy-Clarke G; Burton J; Eseonu A; Lee Y; Chan CC; Egwuagu CE Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6978-86. PubMed ID: 21778271 [TBL] [Abstract][Full Text] [Related]
6. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production. Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603 [TBL] [Abstract][Full Text] [Related]
7. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells. Yu CR; Kim SH; Mahdi RM; Egwuagu CE J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis. Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE Front Immunol; 2020; 11():1051. PubMed ID: 32547555 [TBL] [Abstract][Full Text] [Related]
9. Photoreceptor Cells Constitutively Express IL-35 and Promote Ocular Immune Privilege. Yu CR; Yadav MK; Kang M; Jittayasothorn Y; Dong L; Egwuagu CE Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897732 [TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infection. Yu CR; Hayashi K; Lee YS; Mahdi RM; Shen DF; Chan CC; Egwuagu CE Inflammation; 2015 Apr; 38(2):555-65. PubMed ID: 24993154 [TBL] [Abstract][Full Text] [Related]
11. IFN-beta inhibits human Th17 cell differentiation. Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688 [TBL] [Abstract][Full Text] [Related]
12. Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers Protection. Kim SH; Burton J; Yu CR; Sun L; He C; Wang H; Morse HC; Egwuagu CE J Immunol; 2015 Aug; 195(4):1480-8. PubMed ID: 26163590 [TBL] [Abstract][Full Text] [Related]
13. Effect of SOCS1 overexpression on RPE cell activation by proinflammatory cytokines. Bazewicz M; Draganova D; Makhoul M; Chtarto A; Elmaleh V; Tenenbaum L; Caspers L; Bruyns C; Willermain F Neurosci Lett; 2016 Sep; 630():209-215. PubMed ID: 27478014 [TBL] [Abstract][Full Text] [Related]
14. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. Tanaka K; Ichiyama K; Hashimoto M; Yoshida H; Takimoto T; Takaesu G; Torisu T; Hanada T; Yasukawa H; Fukuyama S; Inoue H; Nakanishi Y; Kobayashi T; Yoshimura A J Immunol; 2008 Mar; 180(6):3746-56. PubMed ID: 18322180 [TBL] [Abstract][Full Text] [Related]
15. Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells. Dagvadorj J; Tumurkhuu G; Naiki Y; Noman AS; Iftakhar-E-Khuda I; Badamtseren B; Komatsu T; Koide N; Yoshida T; Yokochi T Clin Exp Immunol; 2010 Oct; 162(1):169-77. PubMed ID: 20659123 [TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells. Liu X; Mameza MG; Lee YS; Eseonu CI; Yu CR; Kang Derwent JJ; Egwuagu CE Diabetes; 2008 Jun; 57(6):1651-8. PubMed ID: 18356406 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Bhattacharyya S; Zhao Y; Kay TW; Muglia LJ Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9554-9. PubMed ID: 21606371 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. Liu H; Rohowsky-Kochan C J Interferon Cytokine Res; 2011 May; 31(5):459-69. PubMed ID: 21235411 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646 [TBL] [Abstract][Full Text] [Related]
20. The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis. Jager LD; Dabelic R; Waiboci LW; Lau K; Haider MS; Ahmed CM; Larkin J; David S; Johnson HM J Neuroimmunol; 2011 Mar; 232(1-2):108-18. PubMed ID: 21131060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]